Youth Empowerment and Safety Intervention (NCT07214233) | Clinical Trial Compass
RecruitingNot Applicable
Youth Empowerment and Safety Intervention
United States60 participantsStarted 2026-02-23
Plain-language summary
This clinical trial will implement and evaluate the feasibility, acceptability, and initial impact of Peer Support Specialist (PSS) services for public system-involved sexual and gender minority (lesbian, gay, bisexual, queer and/or transgender) youth (SGMY) at risk of suicide.
Who can participate
Age range
12 Years – 17 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Child Inclusion Criteria:
* 12-17 years of age
* Self-identify as a sexual or gender minority (SGM)
* Involved in one or more system: juvenile justice, child welfare, and/or community-based mental health
* Personal experience with self-injurious thoughts and behaviors (SITB)
* English speaking
* Willing and able to provide informed assent
Child Exclusion Criteria:
* Less than 12 or greater than 17 years of age (0-11 or 18 and over)
* Do not self-identify as a sexual or gender minority (SGM)
* Not involved in the juvenile justice, child welfare, and/or community-based mental health systems
* No personal experience with self-injurious thoughts and behaviors (SITB)
* Not English speaking
* Unwilling and/or unable to provide informed assent
Caregiver Inclusion Criteria:
* 18-80 years of age
* Primary Caregiver of youth who meet child inclusion criteria listed above
* English speaking
* Willing and able to provide informed consent
Caregiver Exclusion Criteria:
* Less than 18 or greater than 80 years of age (0-17 or 81 and over)
* Not the Primary Caregiver of youth who meet child inclusion criteria listed above
* Not English speaking
* Unwilling and/or unable to provide informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Youth-level changes in Recovery
Timeframe: Baseline, Post-Intervention 3 Month, and Post Intervention 6 Month
2
Youth Level Changes in Self-injurious thoughts and behaviors
Timeframe: From enrollment (baseline), to 3- and 6 months follow ups post treatment at the end of 8-12 weeks.